Delaying the primary surgical effort for advanced ovarian cancer: A systematic review of neoadjuvant chemotherapy and interval cytoreduction
- 1 February 2007
- journal article
- review article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 104 (2), 480-490
- https://doi.org/10.1016/j.ygyno.2006.11.002
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancerEuropean Journal of Surgical Oncology, 2005
- Can Optimal Primary Cytoreduction Be Predicted in Advanced Stage Epithelial Ovarian Cancer? Role of Preoperative Serum CA-125 LevelGynecologic and Obstetric Investigation, 2004
- The potential role of neoadjuvant chemotherapy in advanced ovarian cancerInternational Journal of Gynecologic Cancer, 2003
- Can Serum CA-125 Levels Predict the Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma?Gynecologic Oncology, 2002
- Can pre-operative computed tomography predict resectability of ovarian carcinoma at primary laparotomy?BJOG: An International Journal of Obstetrics and Gynaecology, 2002
- The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Neoadjuvant chemotherapy for advanced ovarian cancerInternational Journal of Gynecologic Cancer, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Intervention debulking surgery in advanced epithelial ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1994
- Feasibility and outcome of complete secondary tumor resection for patients with advanced ovarian cancerJournal of Surgical Oncology, 1990